Tegafur is a
chemotherapeutic prodrug
A prodrug is a pharmacologically inactive medication or compound that, after intake, is metabolized (i.e., converted within the body) into a pharmacologically active drug. Instead of administering a drug directly, a corresponding prodrug can be ...
of
5-fluorouracil (5-FU) used in the treatment of cancers. It is a component of the combination drug
tegafur/uracil. When metabolised, it becomes 5-FU.
It was patented in 1967 and approved for medical use in 1972.
Medical uses
As a prodrug to 5-FU it is used in the treatment of the following cancers:
*
Stomach
The stomach is a muscular, hollow organ in the upper gastrointestinal tract of Human, humans and many other animals, including several invertebrates. The Ancient Greek name for the stomach is ''gaster'' which is used as ''gastric'' in medical t ...
(when combined with
gimeracil and oteracil)
*
Breast
The breasts are two prominences located on the upper ventral region of the torso among humans and other primates. Both sexes develop breasts from the same embryology, embryological tissues. The relative size and development of the breasts is ...
(with uracil)
*
Gallbladder
In vertebrates, the gallbladder, also known as the cholecyst, is a small hollow Organ (anatomy), organ where bile is stored and concentrated before it is released into the small intestine. In humans, the pear-shaped gallbladder lies beneath t ...
*
Lung
The lungs are the primary Organ (biology), organs of the respiratory system in many animals, including humans. In mammals and most other tetrapods, two lungs are located near the Vertebral column, backbone on either side of the heart. Their ...
(specifically adenocarcinoma, typically with uracil)
*
Colorectal (usually when combined with gimeracil and oteracil)
*
Head and neck
This article describes the anatomy of the head and neck of the human body, including the brain, bones, muscles, blood vessels, nerves, glands, nose, mouth, teeth, tongue, and throat.
Structure Bones
The head rests on the top part of the vertebr ...
*
Liver
The liver is a major metabolic organ (anatomy), organ exclusively found in vertebrates, which performs many essential biological Function (biology), functions such as detoxification of the organism, and the Protein biosynthesis, synthesis of var ...
(with uracil)
*
Pancreatic
It is often given in combination with drugs that alter its bioavailability and toxicity such as gimeracil, oteracil or uracil.
[ These agents achieve this by inhibiting the enzyme ]dihydropyrimidine dehydrogenase
In enzymology, a dihydropyrimidine dehydrogenase (NADP+) () is an enzyme that catalysis, catalyzes the chemical reaction
:5,6-dihydrouracil + NADP+ \rightleftharpoons uracil + NADPH + H+
Thus, the two substrate (biochemistry), substrates of th ...
(uracil/gimeracil) or orotate phosphoribosyltransferase (oteracil).[
]
Adverse effects
The major side effects of tegafur are similar to fluorouracil and include myelosuppression, central neurotoxicity and gastrointestinal toxicity (especially diarrhoea).[ Gastrointestinal toxicity is the dose-limiting side effect of tegafur.][ Central neurotoxicity is more common with tegafur than with fluorouracil.][
]
Pharmacogenetics
The dihydropyrimidine dehydrogenase
In enzymology, a dihydropyrimidine dehydrogenase (NADP+) () is an enzyme that catalysis, catalyzes the chemical reaction
:5,6-dihydrouracil + NADP+ \rightleftharpoons uracil + NADPH + H+
Thus, the two substrate (biochemistry), substrates of th ...
(DPD) enzyme is responsible for the detoxifying metabolism of fluoropyrimidines, a class of drugs that includes 5-fluorouracil, capecitabine
Capecitabine, sold under the brand name Xeloda among others, is a anticancer medication used to treat breast cancer, gastric cancer and colorectal cancer. For breast cancer it is often used together with docetaxel. It is taken by mouth.
...
, and tegafur. Genetic variation
Genetic variation is the difference in DNA among individuals or the differences between populations among the same species. The multiple sources of genetic variation include mutation and genetic recombination. Mutations are the ultimate sources ...
s within the DPD gene (''DPYD'') can lead to reduced or absent DPD activity, and individuals who are heterozygous
Zygosity (the noun, zygote, is from the Greek "yoked," from "yoke") () is the degree to which both copies of a chromosome or gene have the same genetic sequence. In other words, it is the degree of similarity of the alleles in an organism.
Mos ...
or homozygous
Zygosity (the noun, zygote, is from the Greek "yoked," from "yoke") () is the degree to which both copies of a chromosome or gene have the same genetic sequence. In other words, it is the degree of similarity of the alleles in an organism.
Mos ...
for these variations may have partial or complete DPD deficiency; an estimated 0.2% of individuals have complete DPD deficiency. Those with partial or complete DPD deficiency have a significantly increased risk of severe or even fatal drug toxicities when treated with fluoropyrimidines; examples of toxicities include myelosuppression
Bone marrow suppression also known as myelotoxicity or myelosuppression, is the decrease in production of cells responsible for providing immunity (leukocytes), carrying oxygen (erythrocytes), and/or those responsible for normal blood clotting ( ...
, neurotoxicity and hand-foot syndrome.
Mechanism of action
It is a prodrug to 5-FU, which is a thymidylate synthase inhibitor.[
]
Pharmacokinetics
It is metabolised to 5-FU by CYP2A6.
Interactive pathway map
See also
* Tegafur/uracil
* Tegafur/gimeracil/oteracil
References
{{Chemotherapeutic agents
Organofluorides
Prodrugs
Pyrimidinediones
Pyrimidine antagonists
Tetrahydrofurans
Fluoropyrimidines
Drugs in the Soviet Union